Keynote Lecturers

Monday, April 1 | 10:00-11:00a | Auditorium, 2nd Floor, Main Hospital

Adnan A. Hyder, MD, MPH, PhD
Senior Associate Dean for Research, Professor of Global Health, George Washington University

"Emerging and New Challenges to Child Health: A Global Perspective"

Dr. Hyder is Senior Associate Dean for Research and Professor of Global Health at the Milken Institute School of Public Health of George Washington University. Previously, Dr. Hyder served in multiple capacities at the Johns Hopkins Bloomberg School of Public Health. Dr. Hyder has worked to improve global health in low- and middle- income countries with work on health systems, ethics, and injury prevention. He has conducted studies on defining the epidemiological burden, understanding risk factors, exploring potential interventions, estimating economic impact, and appreciating the socio-cultural correlates of non-communicable diseases where he co-authored over 300 scientific peer-reviewed papers. Dr. Hyder received his MD from the Aga Khan University, Pakistan and obtained his MPH and PhD in Public Health from Johns Hopkins University.

Monday, April 1 | 12:00-1:00p | Auditorium, 2nd Floor, Main Hospital

Paule V. Joseph, PhD, MS, FNP-BC, RN, CTN-B
NIH Distinguished Scholar, Assistant Clinical Investigator, Chief of Sensory Science and Metabolism Unit, Biobehavioral Branch, Division of Intramural Research, National Institutes of Nursing Research

"What Mary Poppins Knew: The Science Behind That 'Spoonful of Sugar'"

Dr. Joseph is an Assistant Clinical Investigator and Chief of the Sensory Science and Metabolism Unit (SenSMet) in the NINR Division of Intramural Research. The SenSMet supports research into the fundamental mechanisms associated with chemosensory symptoms and metabolic conditions such as Type 2 diabetes, obesity, and related comorbidities. Dr. Joseph’s clinical chemosensory research aims to improve the diagnosis, prevention, and management of chemosensory disorders and symptoms. This research enhances our understanding of molecular, cellular, neural, and behavioral mechanisms underlying symptoms to identify new targets for treatment and improve symptom management strategies. Dr. Joseph has extensive experience working with individuals with diabetes and obesity. Her experience brings a unique and necessary perspective to the study of chemosensory symptoms (taste and smell alterations) by incorporating both clinical and bench science approaches to unite three fields of science: nursing, sensory biology, and omics.

Tuesday, April 2 | 10:00-11:00a | Auditorium, 2nd Floor, Main Hospital

Vanessa Kerry, MD, MSc
CEO, Seed Global Health

Dr. Kerry is the co-founder and CEO of Seed Global Health – a nonprofit organization which helps provide nursing and medical training support in resource-limited countries. She is a critical care physician at Massachusetts General Hospital and serves as the Associate Director of Partnerships and Global Initiatives at MGH Global Health. She directs the Global Public Policy and Social Change program in the Department of Global Health and Social Medicine at Harvard Medical School, developing research and training on long term health system protection and function.

Tuesday, April 2 | 12:00-1:00p | Auditorium, 2nd Floor, Main Hospital

James M. Wilson, MD, PhD
Rose H. Weiss Professor and Director, Orphan Disease Center, Professor of Medicine and Pediatrics, Director, Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania

"Gene Therapy and Gene Editing for Orphan Diseases"

James M. Wilson, MD, PhD, is a Professor in the Perelman School of Medicine at the University of Pennsylvania where he has led an effort to develop the field of gene therapy. His research career spanning over 40 years has focused on rare diseases and ways to treat them by gene therapy. The Wilson lab identified a new type of vector based on novel isolates of adenoassociated viruses which have become best-in-class for gene therapy being used by over 29 companies. More recently Dr. Wilson's laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.

Wednesday, April 3 | 8:00-9:00a | Auditorium, 2nd Floor, Main Hospital

Larrie Greenberg Grand Rounds Lectureship

Margaret Plack, PT, DPT, EdD
Professor, Doctor of Physical Therapy Program, Department of Health, Human Function & Rehabilitation Sciences, George Washington University

"Think Before You Blink: Using Mindful Reflection to Slow Down and Think Deeply"

Dr. Plack’s ongoing research is related to reflective practice and models of education, which has resulted in over 45 publications and a textbook entitled, Teaching and Learning in Physical Therapy: From Classroom to Clinic. Dr. Plack has provided over 175 educational platforms, posters, presentations and workshops nationally and internationally in a variety of venues including AAMC, PAS, ASPE, NEGEA, and APPTAC. Dr. Plack has received a number of awards for her educational research, including the Stanford Award (2005 and 2007) from the Journal of Physical Therapy Education, the Emerald Literati Network Award (2010) from the Journal of Workplace Learning and the J. Warren Perry Distinguished Author Award (2013) from the Journal of Allied Health. In 2011, she received the Award for Leadership in Education from the Education Section of the American Physical Therapy Association.

Wednesday, April 3 | 12:00-1:00p | Auditorium, 2nd Floor, Main Hospital

Jill Joseph Lectureship

Stephen B. Thomas, PhD
Professor, Health Services Administration, Director, Maryland Center for Health Equity, PI, NIH-NIMHD Center of Excellence on Race, Ethnicity & Health Disparities Research, School of Public Health

"Less Talk More Action: Addressing Unconscious Bias Among Health Professionals"

Dr. Thomas is Director of the Maryland Center for Health Equity and Professor of Health Services Administration in the School of Public Health at the University of Maryland in College Park. Dr. Thomas is one of the nation's leading scholars on community-based interventions to eliminate racial and ethnic health disparities including obesity, diabetes, hypertension, HIV AIDS and violence. He is Principal Investigator of the Center of Excellence on Race, Ethnicity and Disparities Research funded by the NIH-National Institute on Minority Health and Health Disparities (NIMHD), which includes teams of scientists conducting targeted research on obesity, vaccine acceptance and men’s health.

Thursday, April 4 | 10:00-11:00a | Auditorium, 2nd Floor, Main Hospital

Dr. Mendel Tuchman Lectureship

Stephen Goodman, MD
Distinguished Professor of Pediatrics, University of Colorado School of Medicine

"Emerging Concepts in Glutaric Acidemia Type 1"

Dr. Goodman received his MD degree from McGill University in 1963, and has been involved in inborn errors research since he came to the University of Colorado School of Medicine as a research fellow in 1965. Much of his early work was on developing simple gas chromatography-mass spectrometric techniques that could be used to diagnose what are now called organic acidemias and, with the discovery of several previously unrecognized disorders in his laboratory, his efforts focused more on better understanding their genetics, biochemistry, and pathogenesis. He now directs the biochemical genetics laboratory at Children’s Hospital Colorado in Denver, and continues to study disorders of amino acid oxidation at a basic level.

Thursday, April 4 | 12:00-1:00p | Auditorium, 2nd Floor, Main Hospital

Steven A. Rosenberg, MD, PhD
Chief, Surgery Branch, Senior Investiagor, Head, Tumor Immunology Section, National Cancer Institute, National Institutes of Health

"Cell Transfer Immunotherapy for Common Epithelial Cancers"

Dr. Rosenberg is Chief of Surgery at the National Cancer Institute in Bethesda, Maryland. He received his BA and MD degrees at Johns Hopkins University and a PhD in Biophysics at Harvard University. After completing his residency training in surgery in 1974 at the Peter Bent Brigham Hospital in Boston, Massachusetts, Dr. Rosenberg became the Chief of Surgery at the NCI, NIH, a position he has held to the present time. Dr. Rosenberg pioneered the first effective immunotherapies and gene therapies for patients with advanced cancer. His studies of the adoptive transfer of natural or genetically modified lymphocytes have resulted in the regression of metastatic cancer in patients with melanoma, lymphomas and common epithelial cancers. He has published over 1100 peer-reviewed papers.

View Abstract